Polypore mushroom mycelia as an adjunct to COVID-19 vaccination: a randomized clinical trial.

BMC Immunol · 2026 · PMC12955250 · PMID 41620671

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a strong trendp = 0.060so close (0.05 < p ≤ 0.1)

There was a strong trend for a Treatment Group by COVID Exposure Status by Day interaction (Days 1–5) for Side effect Count (F (8,325) = 1.898, p = 0.060; Fig. 3 ).

also in 1,799 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.